Evaluation of bone marrow (BOM) minimal residual disease (MRD) after treatment in children with disseminated neuroblastoma (NB)

M. Brisigotti, M. F. Bonetti, L. Bereich, D. Medicina, G. Fabbretti, A. Garaventa, E. Magrini, B. De Bernard, E. Lanino, C. Rosanda, F. Callea

Research output: Contribution to journalArticle

Abstract

Our aims were (1) to optimize the histological evaluation; (2) to correlate aspiration cytology with histology; (3) to clarify the prognostic implication of MRD. Materials were 201 biopsies, 391 smears from 41 consecutive NB children with BOM involvement at onset, obtained after aggressive chemotherapy with and without BOM or peripheral blood stem cell graft enrolled from June 1995 to May 1996. Methods were routine histology, cytology, and immunocytochemistry (ICC) (polyclonal and monoclonal antibodies NSE, SYN, CROM, S100, MiB1, UJ13A, CD56, and CD45 were used in all cases). Histological parameters included presence of NB cells, degree of differentiation, and type of related stroma. Correlation studies were carried out for 39 of 41 patients on the total number of corresponding samples (176 biopsies versus 300 aspirations) as well as on individual samples from the corresponding site (crista). Sixtythree of 185 representative biopsies (34.6%) were positive (patterns: focal, diffuse, multiple nonconfluent foci, either differentiated or undifferentiated). Up to 100 serial sections were required in 13 of 63 samples from three cases before detecting NB cells. Thirty-five of 391 smears were positive (9% ), 5 of which could be detected only by ICC. The comparison between BOM biopsy and aspiration (b/a) led to the following results: b+/a- in 49 samples; b+/a+ in 14; b-/a+ in 1; b-/a-in 112. In the 49 b+/asamples, the localization pattern was mostly focal (either differentiated or undifferentiated); in the 14 b+/a-f samples it was mainly diffuse undifferentiated. Conclusions: (1) BOM histology is by far more effective than aspiration cytology (34.6% versus 9%) in detecting MRD in treated NB; (2) aspiration cytology is likely to miss the focal (either differentiated or undifferentiated) involvement; (3) the long-term follow-up is expected to clarify the prognostic implications of MRD with special regard to focal involvement after chemotherapy and late relapse.

Original languageEnglish
Pages (from-to)519
Number of pages1
JournalPediatric Pathology and Laboratory Medicine
Volume17
Issue number3
Publication statusPublished - 1997

Fingerprint

Residual Neoplasm
Neuroblastoma
Cell Biology
Bone Marrow
Histology
Biopsy
Immunohistochemistry
Drug Therapy
Needle Biopsy
Therapeutics
Cell Differentiation
Monoclonal Antibodies
Transplants
Recurrence

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Evaluation of bone marrow (BOM) minimal residual disease (MRD) after treatment in children with disseminated neuroblastoma (NB). / Brisigotti, M.; Bonetti, M. F.; Bereich, L.; Medicina, D.; Fabbretti, G.; Garaventa, A.; Magrini, E.; De Bernard, B.; Lanino, E.; Rosanda, C.; Callea, F.

In: Pediatric Pathology and Laboratory Medicine, Vol. 17, No. 3, 1997, p. 519.

Research output: Contribution to journalArticle

Brisigotti, M, Bonetti, MF, Bereich, L, Medicina, D, Fabbretti, G, Garaventa, A, Magrini, E, De Bernard, B, Lanino, E, Rosanda, C & Callea, F 1997, 'Evaluation of bone marrow (BOM) minimal residual disease (MRD) after treatment in children with disseminated neuroblastoma (NB)', Pediatric Pathology and Laboratory Medicine, vol. 17, no. 3, pp. 519.
Brisigotti, M. ; Bonetti, M. F. ; Bereich, L. ; Medicina, D. ; Fabbretti, G. ; Garaventa, A. ; Magrini, E. ; De Bernard, B. ; Lanino, E. ; Rosanda, C. ; Callea, F. / Evaluation of bone marrow (BOM) minimal residual disease (MRD) after treatment in children with disseminated neuroblastoma (NB). In: Pediatric Pathology and Laboratory Medicine. 1997 ; Vol. 17, No. 3. pp. 519.
@article{25fb104ef8b245d38887c5132d52037b,
title = "Evaluation of bone marrow (BOM) minimal residual disease (MRD) after treatment in children with disseminated neuroblastoma (NB)",
abstract = "Our aims were (1) to optimize the histological evaluation; (2) to correlate aspiration cytology with histology; (3) to clarify the prognostic implication of MRD. Materials were 201 biopsies, 391 smears from 41 consecutive NB children with BOM involvement at onset, obtained after aggressive chemotherapy with and without BOM or peripheral blood stem cell graft enrolled from June 1995 to May 1996. Methods were routine histology, cytology, and immunocytochemistry (ICC) (polyclonal and monoclonal antibodies NSE, SYN, CROM, S100, MiB1, UJ13A, CD56, and CD45 were used in all cases). Histological parameters included presence of NB cells, degree of differentiation, and type of related stroma. Correlation studies were carried out for 39 of 41 patients on the total number of corresponding samples (176 biopsies versus 300 aspirations) as well as on individual samples from the corresponding site (crista). Sixtythree of 185 representative biopsies (34.6{\%}) were positive (patterns: focal, diffuse, multiple nonconfluent foci, either differentiated or undifferentiated). Up to 100 serial sections were required in 13 of 63 samples from three cases before detecting NB cells. Thirty-five of 391 smears were positive (9{\%} ), 5 of which could be detected only by ICC. The comparison between BOM biopsy and aspiration (b/a) led to the following results: b+/a- in 49 samples; b+/a+ in 14; b-/a+ in 1; b-/a-in 112. In the 49 b+/asamples, the localization pattern was mostly focal (either differentiated or undifferentiated); in the 14 b+/a-f samples it was mainly diffuse undifferentiated. Conclusions: (1) BOM histology is by far more effective than aspiration cytology (34.6{\%} versus 9{\%}) in detecting MRD in treated NB; (2) aspiration cytology is likely to miss the focal (either differentiated or undifferentiated) involvement; (3) the long-term follow-up is expected to clarify the prognostic implications of MRD with special regard to focal involvement after chemotherapy and late relapse.",
author = "M. Brisigotti and Bonetti, {M. F.} and L. Bereich and D. Medicina and G. Fabbretti and A. Garaventa and E. Magrini and {De Bernard}, B. and E. Lanino and C. Rosanda and F. Callea",
year = "1997",
language = "English",
volume = "17",
pages = "519",
journal = "Pediatric Pathology and Laboratory Medicine",
issn = "1077-1042",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Evaluation of bone marrow (BOM) minimal residual disease (MRD) after treatment in children with disseminated neuroblastoma (NB)

AU - Brisigotti, M.

AU - Bonetti, M. F.

AU - Bereich, L.

AU - Medicina, D.

AU - Fabbretti, G.

AU - Garaventa, A.

AU - Magrini, E.

AU - De Bernard, B.

AU - Lanino, E.

AU - Rosanda, C.

AU - Callea, F.

PY - 1997

Y1 - 1997

N2 - Our aims were (1) to optimize the histological evaluation; (2) to correlate aspiration cytology with histology; (3) to clarify the prognostic implication of MRD. Materials were 201 biopsies, 391 smears from 41 consecutive NB children with BOM involvement at onset, obtained after aggressive chemotherapy with and without BOM or peripheral blood stem cell graft enrolled from June 1995 to May 1996. Methods were routine histology, cytology, and immunocytochemistry (ICC) (polyclonal and monoclonal antibodies NSE, SYN, CROM, S100, MiB1, UJ13A, CD56, and CD45 were used in all cases). Histological parameters included presence of NB cells, degree of differentiation, and type of related stroma. Correlation studies were carried out for 39 of 41 patients on the total number of corresponding samples (176 biopsies versus 300 aspirations) as well as on individual samples from the corresponding site (crista). Sixtythree of 185 representative biopsies (34.6%) were positive (patterns: focal, diffuse, multiple nonconfluent foci, either differentiated or undifferentiated). Up to 100 serial sections were required in 13 of 63 samples from three cases before detecting NB cells. Thirty-five of 391 smears were positive (9% ), 5 of which could be detected only by ICC. The comparison between BOM biopsy and aspiration (b/a) led to the following results: b+/a- in 49 samples; b+/a+ in 14; b-/a+ in 1; b-/a-in 112. In the 49 b+/asamples, the localization pattern was mostly focal (either differentiated or undifferentiated); in the 14 b+/a-f samples it was mainly diffuse undifferentiated. Conclusions: (1) BOM histology is by far more effective than aspiration cytology (34.6% versus 9%) in detecting MRD in treated NB; (2) aspiration cytology is likely to miss the focal (either differentiated or undifferentiated) involvement; (3) the long-term follow-up is expected to clarify the prognostic implications of MRD with special regard to focal involvement after chemotherapy and late relapse.

AB - Our aims were (1) to optimize the histological evaluation; (2) to correlate aspiration cytology with histology; (3) to clarify the prognostic implication of MRD. Materials were 201 biopsies, 391 smears from 41 consecutive NB children with BOM involvement at onset, obtained after aggressive chemotherapy with and without BOM or peripheral blood stem cell graft enrolled from June 1995 to May 1996. Methods were routine histology, cytology, and immunocytochemistry (ICC) (polyclonal and monoclonal antibodies NSE, SYN, CROM, S100, MiB1, UJ13A, CD56, and CD45 were used in all cases). Histological parameters included presence of NB cells, degree of differentiation, and type of related stroma. Correlation studies were carried out for 39 of 41 patients on the total number of corresponding samples (176 biopsies versus 300 aspirations) as well as on individual samples from the corresponding site (crista). Sixtythree of 185 representative biopsies (34.6%) were positive (patterns: focal, diffuse, multiple nonconfluent foci, either differentiated or undifferentiated). Up to 100 serial sections were required in 13 of 63 samples from three cases before detecting NB cells. Thirty-five of 391 smears were positive (9% ), 5 of which could be detected only by ICC. The comparison between BOM biopsy and aspiration (b/a) led to the following results: b+/a- in 49 samples; b+/a+ in 14; b-/a+ in 1; b-/a-in 112. In the 49 b+/asamples, the localization pattern was mostly focal (either differentiated or undifferentiated); in the 14 b+/a-f samples it was mainly diffuse undifferentiated. Conclusions: (1) BOM histology is by far more effective than aspiration cytology (34.6% versus 9%) in detecting MRD in treated NB; (2) aspiration cytology is likely to miss the focal (either differentiated or undifferentiated) involvement; (3) the long-term follow-up is expected to clarify the prognostic implications of MRD with special regard to focal involvement after chemotherapy and late relapse.

UR - http://www.scopus.com/inward/record.url?scp=33748138233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748138233&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 519

JO - Pediatric Pathology and Laboratory Medicine

JF - Pediatric Pathology and Laboratory Medicine

SN - 1077-1042

IS - 3

ER -